Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
Monika Janda, Val Gebski, Alison Brand, Russel Hogg, Thomas W Jobling, Russel Land, Tom Manolitsas, Anthony McCartney, Marcelo Nascimento, Deborah Neesham, James L Nicklin, Martin K Oehler, Geoff Otton, Lewis Perrin, Stuart Salfinger, Ian Hammond, Yee Leung, Tom Walsh, Peter Sykes, Hextan Ngan, Andrea Garrett, Michael Laney, Tong Yow Ng, Karfai Tam, Karen Chan, C David H Wrede, Selvan Pather, Bryony Simcock, Rhonda Farrell, Andreas Obermair
20100701
2010 Aug 1
Lancet Oncol
Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
Lancet Oncol. 2010 Aug;11(8):772-780, Monika Janda, Val Gebski, Alison Brand, Russel Hogg, Thomas W Jobling, Russel Land, Tom Manolitsas, Anthony McCartney, Marcelo Nascimento, Deborah Neesham, James L Nicklin, Martin K Oehler, Geoff Otton, Lewis Perrin, Stuart Salfinger, Ian Hammond, Yee Leung, Tom Walsh, Peter Sykes, Hextan Ngan, Andrea Garrett, Michael Laney, Tong Yow Ng, Karfai Tam, Karen Chan, C David H Wrede, Selvan Pather, Bryony Simcock, Rhonda Farrell, Andreas Obermair
Background This two-stage randomised controlled trial, comparing total laparoscopic hysterectomy (TLH) with total abdominal hysterectomy (TAH) for stage I endometrial cancer (LACE), began in 2005. The primary objective of stage 1 was to assess whether TLH results in equivalent or improved quality of life (QoL) up to 6 months after surgery compared with TAH. The primary objective of stage 2 was to test the hypothesis that disease-free survival at 4·5 years is equivalent for TLH and TAH. Here,...
Editors' Choice
Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)
